Mackenzie Financial Corp raised its holdings in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) by 122.3% in the third quarter, Holdings Channel reports. The institutional investor owned 52,587 shares of the biotechnology company’s stock after acquiring an additional 28,931 shares during the period. Mackenzie Financial Corp’s holdings in BioCryst Pharmaceuticals were worth $663,000 […]
Russell Investments Group Ltd Invests $29,000 in BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.